Rescuing Mitochondrial Dysfunction in Macrophages Prevents Osteonecrosis of the Jaw in Anti‐Resorptive Therapy
Advanced Science · 2026-02 · 13 (11)
DOI: 10.1002/advs.202517586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 07.12.2025. Verfasst von Hang Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases, Nanjing Medical University, Nanjing, 210029, China. Hauptthemen laut MEDLINE: Mitochondria, Macrophages, Zoledronic Acid, Bisphosphonate-Associated Osteonecrosis of the Jaw. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Education-Jiangsu Provincial Research Hospital Cultivation Unit, Jiangsu Provincial Medical Innovation Center.
Abstract (Originalsprache)
Mitochondria‐driven macrophage dysregulation contributes significantly to inflammatory disease progression; however, the mechanism underlying bisphosphonate‐related osteonecrosis of the jaw (BRONJ) remains unclear. This study demonstrates that zoledronic acid (ZA) disrupts mitochondrial bioenergetic function in macrophages, leading to elevated mitochondrial membrane potential, excessive mitochondrial reactive oxygen species (mtROS), and increased HIF‐1α expression, which together promote a pro‐inflammatory transition in macrophages. ZA further inhibits autophagy by activating the TLR4‐MyD88/PI3K‐AKT‐mTOR pathway, preventing the clearance of dysfunctional mitochondria and sustaining superoxide production. Genetic loss of Atg5 in innate immune cells disrupts autophagosome maturation and markedly worsens ZA‐induced BRONJ development. To restore mitochondrial degradation and biofunction, ZA‐loaded nanoparticles incorporating the mTOR inhibitor rapamycin (ZDPR) are developed. ZDPR effectively prevents BRONJ and exerts therapeutic benefits in osteoporosis and osteolysis. These findings highlight bone‐targeted mitochondria rescue as a promising strategy to enhance antiresorptive therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases, Nanjing Medical University, Nanjing, 210029, China.
- Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, 210029, China.
- Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing Medical University, Nanjing, 210029, China.
- Department of Orthopaedics, Orthopaedic Trauma Institute (OTI), Trauma Center, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China.
- State Key Lab of Digital Medical Engineering, Jiangsu Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 211189, China.
ORCID-Profile: Hang Zhang, Hongbing Jiang
Förderung
- National Natural Science Foundation of China
- Education-Jiangsu Provincial Research Hospital Cultivation Unit
- Jiangsu Provincial Medical Innovation Center
Zitieren
APA
Zhang, H., Shen, X., Liu, H., Yuan, X., Cao, M., Lv, X., Ling, Z., Guo, S., Xu, R., Li, X., & Jiang, H. (2026). Rescuing Mitochondrial Dysfunction in Macrophages Prevents Osteonecrosis of the Jaw in Anti‐Resorptive Therapy. Advanced Science, 13(11). https://doi.org/10.1002/advs.202517586
Vancouver
Zhang H, Shen X, Liu H, Yuan X, Cao M, Lv X, et al. Rescuing Mitochondrial Dysfunction in Macrophages Prevents Osteonecrosis of the Jaw in Anti‐Resorptive Therapy. Advanced Science. 2026;13(11). doi:10.1002/advs.202517586
BibTeX
@article{Zhang2026,
author = {Zhang, Hang and Shen, Xin and Liu, Haiyang and Yuan, Xinxi and Cao, Mumin and Lv, Xuepeng and Ling, Ziji and Guo, Songsong and Xu, Rongyao and Li, Xiang and Jiang, Hongbing},
title = {Rescuing Mitochondrial Dysfunction in Macrophages Prevents Osteonecrosis of the Jaw in Anti‐Resorptive Therapy},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {11},
doi = {10.1002/advs.202517586}
}
EUVIMED